Lobby organisation
Johnson & Johnson
Company · Health & pharma · HQ: United States · Transparency Register entry
As of 7 November 2026, Johnson & Johnson appears in 79 declared MEP meetings (50 different MEPs), most often with European People's Party.
In their own words
“At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life.”
Read the rest of the statementShow less of the statement
“Today, as the world’s largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 79 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2019–2026. Bar length is relative to its busiest year (29 in 2025). Hatched: 2026 is a part-year - the record runs to 6 Nov 2026.
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 15 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 20 Oct 2026 | Diego Solier | Exchange of Views |
| 20 Oct 2026 | Tiemo Wölken | MDR/IVDR Revision and Biotech Act |
| 11 Sep 2026 | Karin Karlsbro | Battery labeling |
| 3 Sep 2026 | András Tivadar Kulja | Biotech |
| 30 Jun 2026 | Carlo Ciccioli | Biotech Act |
| 23 Jun 2026 | Lukas Mandl | Biotech Act I |
| 9 Jun 2026 | Kristoffer Storm | EU Biotech Act |
| 2 Jun 2026 | Kristian Vigenin | Biotech Act |
| 1 Jun 2026 | András Gyürk | EU Biotech Act |
| 1 Jun 2026 | Viktória Ferenc | Introduction, exchange of views on Biotech Act |
| 26 May 2026 | Tiemo Wölken | Biotech Act |
| 20 May 2026 | Elena Nevado del Campo | Biotech Act |
| 11 May 2026 | Margarita de la Pisa Carrión | SANT COMMITTEE ONGOING WORK |
| 29 Apr 2026 | Nicolás González Casares | Pharmaceutical Policy EU-US Trade |
| 28 Apr 2026 | Ingeborg ter Laak | Biotech Act |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.